Ralph W. Niven

2.1k total citations
46 papers, 1.7k citations indexed

About

Ralph W. Niven is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Ralph W. Niven has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Ralph W. Niven's work include Inhalation and Respiratory Drug Delivery (27 papers), Neonatal Respiratory Health Research (5 papers) and Immune Response and Inflammation (5 papers). Ralph W. Niven is often cited by papers focused on Inhalation and Respiratory Drug Delivery (27 papers), Neonatal Respiratory Health Research (5 papers) and Immune Response and Inflammation (5 papers). Ralph W. Niven collaborates with scholars based in United States, Germany and France. Ralph W. Niven's co-authors include Hans Schreier, David A. Edwards, Peter R. Byron, Janet G. Smith, Joseph D. Brain, Daniel J. Freeman, Fred D. Lott, Steven J. Prestrelski, Tsutomu Arakawa and Steven D. Mittelman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Ralph W. Niven

46 papers receiving 1.6k citations

Peers

Ralph W. Niven
Theresa D. Sweeney United States
Mary Lou Eskew United States
Cynthia Bosquillon United Kingdom
A. Ben-Jebria United States
J. Clifford Waldrep United States
Christopher Marriott United Kingdom
Ralph W. Niven
Citations per year, relative to Ralph W. Niven Ralph W. Niven (= 1×) peers Tobias Gessler

Countries citing papers authored by Ralph W. Niven

Since Specialization
Citations

This map shows the geographic impact of Ralph W. Niven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph W. Niven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph W. Niven more than expected).

Fields of papers citing papers by Ralph W. Niven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph W. Niven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph W. Niven. The network helps show where Ralph W. Niven may publish in the future.

Co-authorship network of co-authors of Ralph W. Niven

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph W. Niven. A scholar is included among the top collaborators of Ralph W. Niven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph W. Niven. Ralph W. Niven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gillies, Hunter, Murali M. Chakinala, Benjamin T. Dake, et al.. (2024). IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension. Pulmonary Circulation. 14(1). e12352–e12352. 5 indexed citations
2.
Corcoran, Timothy E., Ralph W. Niven, Wendy Verret, Stephen Dilly, & B. A. Johnson. (2013). Lung Deposition and Pharmacokinetics of Nebulized Cyclosporine in Lung Transplant Patients. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 27(3). 178–184. 19 indexed citations
3.
Niven, Ralph W., et al.. (2011). Safety and Toxicology of Cyclosporine in Propylene Glycol after 9-Month Aerosol Exposure to Beagle Dogs. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 24(4). 205–212. 10 indexed citations
4.
Kinniry, Paul, Deepika Jain, Charalambos Solomides, et al.. (2006). KL4‐surfactant prevents hyperoxic and LPS‐induced lung injury in mice. Pediatric Pulmonology. 41(10). 916–928. 32 indexed citations
5.
Niven, Ralph W.. (1997). Dry powder formulations for inhalation. Advanced Drug Delivery Reviews. 26(1). 9 indexed citations
6.
Niven, Ralph W., et al.. (1995). Systemic Absorption and Activity of Recombinant Consensus Interferons After Intratracheal Instillation and Aerosol Administration. Pharmaceutical Research. 12(12). 1889–1895. 12 indexed citations
7.
Arakawa, Tsutomu, et al.. (1995). Stability of Recombinant Consensus Interferon to Air‐Jet and Ultrasonic Nebulization. Journal of Pharmaceutical Sciences. 84(10). 1210–1214. 35 indexed citations
8.
Niven, Ralph W.. (1995). Delivery of Biotherapeutics by Inhalation Aerosol. Critical Reviews in Therapeutic Drug Carrier Systems. 12(2-3). 151–231. 125 indexed citations
9.
Niven, Ralph W., et al.. (1995). The Pulmonary Absorption of Aerosolized and Intratracheally Instilled rhG-CSF and monoPEGylated rhG-CSF. Pharmaceutical Research. 12(9). 1343–1349. 65 indexed citations
10.
Niven, Ralph W., et al.. (1995). Some Factors Associated with the Ultrasonic Nebulization of Proteins. Pharmaceutical Research. 12(1). 53–59. 69 indexed citations
11.
Litzinger, David C., et al.. (1995). A method for preparing chelate-cytokine conjugates with retention of protein structure, biological activity, and pharmacokinetic properties. Journal of Immunological Methods. 187(1). 151–161. 6 indexed citations
12.
Niven, Ralph W., et al.. (1994). Pulmonary Delivery of Powders and Solutions Containing Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) to the Rabbit. Pharmaceutical Research. 11(8). 1101–1109. 43 indexed citations
13.
Wolff, Ronald K. & Ralph W. Niven. (1994). Generation of Aerosolized Drugs. Journal of Aerosol Medicine. 7(1). 89–106. 29 indexed citations
14.
Niven, Ralph W., et al.. (1994). Prediction and Experimental Determination of Solute Output from a Collison Nebulizer. Journal of Pharmaceutical Sciences. 83(7). 1047–1051. 13 indexed citations
15.
Myers, Mark A., Ralph W. Niven, Matthieu L. Kaltenbach, et al.. (1993). Pulmonary Effects of Chronic Exposure to Liposome Aerosols in Mice. Experimental Lung Research. 19(1). 1–19. 57 indexed citations
16.
Niven, Ralph W., Robert M. Kacmarek, Joseph D. Brain, & Robert A. Peterfreund. (1993). Small Bore Nozzle Extensions to Improve the Delivery Efficiency of Drugs from Metered Dose Inhalers: Laboratory Evaluation. American Review of Respiratory Disease. 147(6_pt_1). 1590–1594. 20 indexed citations
17.
Niven, Ralph W., et al.. (1991). Nebulization of Liposomes. II. The Effects of Size and Modeling of Solute Release Profiles. Pharmaceutical Research. 8(2). 217–221. 71 indexed citations
18.
Niven, Ralph W. & Hans Schreier. (1990). Nebulization of Liposomes. I. Effects of Lipid Composition. Pharmaceutical Research. 7(11). 1127–1133. 95 indexed citations
19.
Niven, Ralph W., František Rypáček, & Peter R. Byron. (1990). Solute Absorption from the Airways of the Isolated Rat Lung. III. Absorption of Several Peptidase-Resistant, Synthetic Polypeptides: Poly-(2-Hydroxyethyl)-Aspartamides. Pharmaceutical Research. 7(10). 990–994. 32 indexed citations
20.
Byron, Peter R. & Ralph W. Niven. (1988). A novel dosing method for drug administration to the airways of the isolated perfused rat lung. Journal of Pharmaceutical Sciences. 77(8). 693–695. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026